Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NS102414)
Amyotrophic Lateral Sclerosis Association (16-IIP-287)
Received: 24 January 2020
Accepted: 11 August 2020
First Online: 15 September 2020
Change Date: 1 October 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
: J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, Novartis, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from genetic testing offered at Baylor Genetics (ExternalRef removed). J.R.L. serves on the Scientific Advisory Board of Baylor Genetics. G.D. is an employee of GeneDx, Inc. The remaining authors declare no competing interests.